Small and midsize customers take advantage of innovations and enterprise-class capabilities to drive business results Dell adds back-up and recovery functionality to PowerEdge VRTX Dell Financial ...

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INCORPORATED (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our Twin Momentum Investor model based on ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

View Vertex Pharmaceuticals Incorporated (VRTX) current and estimated P/E ratio data provided by Seeking Alpha.

For Vertex, the consensus sales estimate for the current quarter of $2.68 billion indicates a year-over-year change of +7.8%. For the current and next fiscal years, $10.74 billion and $11.8 ...

Vertex Pharmaceuticals Incorporated VRTX reported second-quarter 2024 results on Aug 1. Adjusted loss per share of $12.83 was wider than the Zacks Consensus Estimate of a loss of $11.50.

Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics Jim Cramer discusses Serve Robotics, Builders FirstSource, Vertex Pharmaceuticals and Viking ...

You can quickly switch between laptop mode and tablet mode with the help of the 360-degree hinges that are attached to its 16-inch 1920 x 1200 resolution touchscreen. The Dell Inspiron 16 2-in-1 ...

Vertex Pharmaceuticals (VRTX) closed at $489.43 in the latest trading session, marking a +0.84% move from the prior day. This move outpaced the S&P 500's daily gain of 0.13%. At the same time ...